Skip to content

Sofosbuvir/velpatasvir + GS-9857 works well for treatment-experienced hepatitis C patients

Eric Lawitz of the Texas Liver Institute presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C treatment may not be enough to stop the progress of advanced liver disease, or reduce liver transplant need

Dr Carlos Fernández Carrillo presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com

$300 hepatitis C combination to enter clinical trials

Primary care doctors and nurse practitioners can successfully treat people with hepatitis C

A third of MSM with HIV/HCV co-infection have HCV in their semen

HCV epidemic in North America peaked between 1940 and 1965 with medical procedures likely source of most infections

Opt-out HIV/HBV/HCV testing for patients attending emergency departments identifies significant number of new infections

Starting HIV therapy associated with improvements in liver function, especially when viral load is suppressed

HIV-related factors increase risk of stroke